For research use only. Not for therapeutic Use.
Bezlotoxumab is a human monoclonal antibody directed against C. difficile toxin B. Bezlotoxumab binds to C. difficile toxin B preventing intestinal epithelial damage and colitis[1].
| Catalog Number | I041615 |
| CAS Number | 1246264-45-8 |
| Purity | ≥95% |
| Reference | [1]. Navalkele BD, et, al. Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection. Biologics. 2018 Jan 18;12:11-21. |
